FDA Updates Breakthrough Device Criteria
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- STAT+ restricts the full analysis of the FDA’s updated breakthrough device criteria to paying subscribers, requiring a subscription to read the article.
- FDA is referenced in the title as updating breakthrough device criteria, but the article provides no specific details on the changes.
- CMMI ACCESS Model had its first cohort application deadline on April 1, as highlighted in the article’s introductory note.
- Mario Aguilar authored the piece, which was published on April 2, 2026 as part of STAT’s Health Tech newsletter.
Why it matters: Patients and innovators seeking FDA‑approved AI devices must wait for the paywalled analysis, while industry stakeholders who subscribe to STAT+ gain early insight; the April 1 CMMI ACCESS deadline creates a narrow window for funding applications, and the article’s April 2, 2026 publication signals timely relevance.
